Patent classifications
A62D3/38
RECONSTRUCTION SOLUTION FOR REMOVING COATINGS OF CARCINOGENIC FIBERS USING AN ORGANIC OR INORGANIC CONTRAST AGENT FOR VISUALIZING THE PENETRATION OF HYDROCHLORIC ACID INTO CARCINOGENIC FIBERS
A pH-stable dye which allows the penetration of hydrochloric acid into amorphically different carcinogenic fibers used for detection of sprayed asbestos or plastic mineral fibers for fireproofing components. In the process, the continuous colored penetration of the fiber layers is achieved synchronously with the decomposition process of the hydrochloric add. Thus, the progress of the penetration process can be estimated during the reconstruction work, and the task of removing the now spongy layers can be carried out with contrast agents of the following group consisting of organic and inorganic substances such as acridine orange, brilliant cresyl blue, bromophenol blue, eosin Y, erythrosine B, fluorescein, methyl blue, methyl orange, thymol blue, resulting in the even penetration of carcinogenic fibers using hydrochloric acid.
RECONSTRUCTION SOLUTION FOR REMOVING COATINGS OF CARCINOGENIC FIBERS USING AN ORGANIC OR INORGANIC CONTRAST AGENT FOR VISUALIZING THE PENETRATION OF HYDROCHLORIC ACID INTO CARCINOGENIC FIBERS
A pH-stable dye which allows the penetration of hydrochloric acid into amorphically different carcinogenic fibers used for detection of sprayed asbestos or plastic mineral fibers for fireproofing components. In the process, the continuous colored penetration of the fiber layers is achieved synchronously with the decomposition process of the hydrochloric add. Thus, the progress of the penetration process can be estimated during the reconstruction work, and the task of removing the now spongy layers can be carried out with contrast agents of the following group consisting of organic and inorganic substances such as acridine orange, brilliant cresyl blue, bromophenol blue, eosin Y, erythrosine B, fluorescein, methyl blue, methyl orange, thymol blue, resulting in the even penetration of carcinogenic fibers using hydrochloric acid.
CT value controller and anticancer agent degradation apparatus
A CT value controller includes a storage means, an input means, and a computing means. The storage means stores a function expressing a relative humidity and a CT value regarding a degradation degree of an anticancer agent, an assumed relative humidity, and a CT setting. The input means inputs a measured relative humidity and a measured ozone concentration at a time of degradation treatment of the anticancer agent. The computing means calculates a corrected CT value increment based on a difference between the measured relative humidity and the assumed relative humidity at every input of the relative humidity and the ozone concentration by using the function. The computing means determines a termination of the degradation treatment of the anticancer agent when an integrated CT value of the corrected CT value increments reaches the CT setting.
CT value controller and anticancer agent degradation apparatus
A CT value controller includes a storage means, an input means, and a computing means. The storage means stores a function expressing a relative humidity and a CT value regarding a degradation degree of an anticancer agent, an assumed relative humidity, and a CT setting. The input means inputs a measured relative humidity and a measured ozone concentration at a time of degradation treatment of the anticancer agent. The computing means calculates a corrected CT value increment based on a difference between the measured relative humidity and the assumed relative humidity at every input of the relative humidity and the ozone concentration by using the function. The computing means determines a termination of the degradation treatment of the anticancer agent when an integrated CT value of the corrected CT value increments reaches the CT setting.
Controlled medication denaturing composition
A composition for decomposing pharmaceutically active agents, comprises up to 30 wt. % oxidizer; and up to 30 wt. % immobilizer; wherein the wt. % is based on a total weight of the composition.
Controlled medication denaturing composition
A composition for decomposing pharmaceutically active agents, comprises up to 30 wt. % oxidizer; and up to 30 wt. % immobilizer; wherein the wt. % is based on a total weight of the composition.
Hydrothermal Technology for Decontamination and Mineralization of Perfluoro- and Polyfluoroalkyl Substance (PFAS) in Wastes, Concentrate Solutions, and Chemical Stockpiles
Disclosed herein are methods and systems for treating a waste substance containing perfluoro- and polyfluoroalkyl substances (PFAS). The method includes combining the PFAS with a first amendment in a reactor to create a combination, heating and pressurizing the combination to hydrothermal conditions, and holding the combination at hydrothermal conditions for a holding time sufficient to at least partially mineralize the PFAS to create a treated combination.
Hydrothermal Technology for Decontamination and Mineralization of Perfluoro- and Polyfluoroalkyl Substance (PFAS) in Wastes, Concentrate Solutions, and Chemical Stockpiles
Disclosed herein are methods and systems for treating a waste substance containing perfluoro- and polyfluoroalkyl substances (PFAS). The method includes combining the PFAS with a first amendment in a reactor to create a combination, heating and pressurizing the combination to hydrothermal conditions, and holding the combination at hydrothermal conditions for a holding time sufficient to at least partially mineralize the PFAS to create a treated combination.
Pigmented decontaminating gel and method for decontaminating surfaces using said gel
A decontamination gel is provided consisting of a colloidal solution comprising 0.1% to 30% by mass, preferably 0.1% to 25% by mass, still more preferably from 5% to 25% by mass, even more preferably 8% to 20% by mass, based on the mass of the gel, of at least one inorganic viscosifying agent; 0.1 to 10 mol/L of gel, preferably 0.5 to 10 mol/L of gel, still more preferably 1 to 10 mol/L of gel of at least one active decontamination agent; 0.01% to 10% by mass, preferably 0.1% to 5% by mass based on the mass of the gel of at least one mineral pigment; optionally, 0.1% to 2% by mass based on the mass of the gel, of at least one surfactant; optionally, 0.05% to 5% by mass, preferably 0.05% to 2% by mass, based on the mass of the gel, of at least one super-absorbent polymer; and the balance of solvent.
Pigmented decontaminating gel and method for decontaminating surfaces using said gel
A decontamination gel is provided consisting of a colloidal solution comprising 0.1% to 30% by mass, preferably 0.1% to 25% by mass, still more preferably from 5% to 25% by mass, even more preferably 8% to 20% by mass, based on the mass of the gel, of at least one inorganic viscosifying agent; 0.1 to 10 mol/L of gel, preferably 0.5 to 10 mol/L of gel, still more preferably 1 to 10 mol/L of gel of at least one active decontamination agent; 0.01% to 10% by mass, preferably 0.1% to 5% by mass based on the mass of the gel of at least one mineral pigment; optionally, 0.1% to 2% by mass based on the mass of the gel, of at least one surfactant; optionally, 0.05% to 5% by mass, preferably 0.05% to 2% by mass, based on the mass of the gel, of at least one super-absorbent polymer; and the balance of solvent.